Daklinza and Weight decreased - a phase IV clinical study of FDA data

Summary:

Weight decreased is reported as a side effect among people who take Daklinza (daclatasvir dihydrochloride), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Sovaldi, and have Hepatitis c.

The phase IV clinical study analyzes which people have Weight decreased when taking Daklinza. It is created by eHealthMe based on reports of 3,308 people who have side effects when taking Daklinza from the FDA, and is updated regularly.

What is Daklinza?

Daklinza has active ingredients of daclatasvir dihydrochloride. eHealthMe is studying from 3,312 Daklinza users. Check the latest studies of Daklinza.

What is Weight decreased?

Weight decreased is found to be associated with 3,377 drugs and 4,759 conditions by eHealthMe. Check the latest studies of Weight decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

3,308 people reported to have side effects when taking Daklinza.
Among them, 31 people (0.94%) have Weight decreased.

Among these 31 people:

How long have people been on Daklinza when they have Weight decreased? *

What is the gender of people who have Weight decreased when taking Daklinza? *

female: 35.48 %
male: 64.52 %

What is the age of people who have Weight decreased when taking Daklinza? *

What are other drugs people take besides Daklinza? *

What are other side effects people have besides Weight decreased? *

Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 15 people, 48.39%
Weakness: 12 people, 38.71%
Fatigue (feeling of tiredness): 12 people, 38.71%
Insomnia (sleeplessness): 9 people, 29.03%
Headache (pain in head): 9 people, 29.03%
Nausea (feeling of having an urge to vomit): 9 people, 29.03%
Confusional State: 7 people, 22.58%
Fever: 7 people, 22.58%
Pain In Extremity: 7 people, 22.58%
Abnormal Faeces (abnormal stool): 7 people, 22.58%

What are the existing conditions these people have? *

Hepatitis C: 7 people, 22.58%
Urticaria (rash of round, red welts on the skin that itch intensely): 6 people, 19.35%
Tropical Spastic Paresis (an incurable viral infection of the spinal cord that causes weakness in the legs): 6 people, 19.35%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 6.45%
Diabetes: 2 people, 6.45%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 6.45%
Visual Impairment: 1 person, 3.23%
Thyroid Mass: 1 person, 3.23%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 3.23%
Hepatitis C Rna Increased: 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Daklinza and have Weight decreased?

- Check whether Weight decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daklinza:

Daklinza (3,312 reports)

Weight decreased treatments and more:

Weight decreased (364,522 reports)

Browse all side effects of Daklinza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight decreased:

Weight decreased (3,377 drugs)

Browse all the conditions that are associated with Weight decreased:

Weight decreased (4,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on daclatasvir dihydrochloride (the active ingredients of Daklinza) and Daklinza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.